Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Researchers characterize novel subtype of endocervical adenocarcinoma

Key clinical point: A novel subtype of endocervical adenocarcinoma has been characterized by high resistance to therapy and poor survival.

Major finding: Gastric-type mucinous carcinoma is a distinct variant of endocervical mucinous adenocarcinoma significantly associated with poor clinical outcomes.

Study details: A retrospective histopathological analysis of 393 women with stage I or II endocervical adenocarcinoma.

Disclosures: The study was funded by the National Cancer Center Research and Development Fund of Japan. The authors reported no conflicts of interest.

Citation:

Nishio S et al. Gynecol Oncol. 2019 Jan 29. doi: 10.1016/j.ygyno.2019.01.022.